2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures
2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures
复制标题
DOI:
10.1016/j.jacc.2016.03.521
复制
发表时间:
2016-07-01
影响因子:
6.9
通讯作者:
Varosy, Paul D.
中科院分区:
文献类型:
--
作者:
Heidenreich, Paul A.;Solis, Penelope;Varosy, Paul D.
In the summer of 2015, the ACC/AHA convened the writing committee to begin the process of revising the existing atrial fibrillation (AF) and atrial flutter measure set that was released in 20082 and for which implementation notes had been issued in 2011. 3 The writing committee also was charged with the task of developing new measures to benchmark and improve the quality of care for patients with AF or atrial flutter. Throughout the report, the term AF will include atrial flutter, unless specifically stated.All the measures included in the clinical performance and quality measure set are briefly summarized in Table 1, which provides information on the measure number, measure title, and care setting. The detailed measure specifications (available in Appendix A) provide not only the information included in Table 1 but also more detailed information, including the measure description, numerator, denominator (including denominator exclusions and exceptions), rationale for the measure, guidelines that support the measure, measurement period, source of data, and attribution. This AF clinical performance and quality measure set is notable for several reasons. First, the writing committee considered whether measures should be developed for the inpatient setting, expanding the scope of the original measure set. Specifically, the writing committee decided to broaden the care setting, from a solely outpatient context to the inpatient setting, to further improve the continuity of care for these patients by addressing the multiple settings in which they receive care. Second, new measures were developed for care domains that were not previously addressed, including patient safety, effective clinical care, communication, and care coordination. Many measure concepts were considered but were ultimately not included in this set after committee discussion. It is the hope of this writing committee that this clinical performance and quality measure set will be reassessed as new science is developed and as electronic health record data standards are more broadly implemented across settings.